ArticleFrontiers in oncology2023

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy.

Long-Hai Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.